Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature
Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma. Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports. The objective of this study is to report a case of borte...
Saved in:
Main Authors: | Prakash Kharel, Deekchha Uprety, Abhinav B. Chandra, Yirui Hu, Anuradha Avinash Belur, Ajay Dhakal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/2913124 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature
by: Mor Moskovitz, et al.
Published: (2015-01-01) -
Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia
by: E. Vandeix, et al.
Published: (2012-01-01) -
Case report: Therapeutic use of bortezomib in a patient with Schnitzler syndrome
by: Hua Bai, et al.
Published: (2025-01-01) -
Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
by: Bhanu K. Patibandla, et al.
Published: (2014-01-01) -
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments
by: Belluzzi L, et al.
Published: (2025-01-01)